EPCAM and non-small cell lung carcinoma: Recently, Janning and colleagues [29] compared the EpCAM-based CellSearch® System with the epitope-independent ParsortixTM system (Angle) for the assessment of PD-L1 expression of CTCs extracted from NSCLC patients.